Giulia Morsica

Summary

Affiliation: San Raffaele Scientific Institute
Country: Italy

Publications

  1. pmc Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report
    Sabrina Bagaglio
    Infectious Diseases Department, San Raffaele, Scientific Institute, via Stamira D Ancona, Milano 20127, Italy
    J Med Case Reports 3:110. 2009
  2. ncbi Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression
    Giulia Morsica
    Division of Infectious Diseases, San Raffaele, Scientific Institute, via Stamira d Ancona n 20, 20127 Milan, Italy
    J Clin Virol 39:82-6. 2007
  3. ncbi Hepatic safety profile of darunavir with low-dose ritonavir (DRV/r) in HIV/HCV coinfected and HIV monoinfected patients
    Giulia Morsica
    Department of Infectious Diseases, San Raffaele, Scientific Institute, Milan, Italy
    New Microbiol 34:317-21. 2011
  4. doi Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features
    G Morsica
    Dept of Infectious Diseases, S Raffaele Scientific Institute, Milan, Italy
    Infection 37:445-9. 2009
  5. doi Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients
    Giulia Morsica
    Department of Infectious Diseases, San Raffaele, Scientific Institute, Milan, Italy
    J Acquir Immune Defic Syndr 51:574-81. 2009
  6. ncbi Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy
    Giovanni Sitia
    Infectious Disease Department, San Raffaele Scientific Institute, Milan, Italy
    Antivir Ther 11:385-9. 2006
  7. ncbi Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients
    Sabrina Bagaglio
    Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
    AIDS 19:S151-65. 2005
  8. doi Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs
    Hamid Hasson
    Department of Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
    Liver Int 33:1113-20. 2013
  9. ncbi HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study)
    Hamid Hasson
    Department of Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
    New Microbiol 35:469-74. 2012
  10. ncbi Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy
    Caterina Uberti-Foppa
    Department of Infectious Diseases, Vita Salute San Raffaele University, Via Stamira d Ancona 20, 20127 Milan, Italy
    J Acquir Immune Defic Syndr 33:146-52. 2003

Detail Information

Publications17

  1. pmc Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report
    Sabrina Bagaglio
    Infectious Diseases Department, San Raffaele, Scientific Institute, via Stamira D Ancona, Milano 20127, Italy
    J Med Case Reports 3:110. 2009
    ..There seem to be no published data concerning the clinical impact of populations of hepatitis B virus (HBV) in the hepatic and extrahepatic compartments of HIV-infected people with severe acute hepatitis...
  2. ncbi Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression
    Giulia Morsica
    Division of Infectious Diseases, San Raffaele, Scientific Institute, via Stamira d Ancona n 20, 20127 Milan, Italy
    J Clin Virol 39:82-6. 2007
    ..Hepatitis C virus (HCV) infection is frequent in HIV-positive subjects. We evaluated the potential impact of HCV coinfection and other determinants on HIV disease progression in a cohort of long-term non-progressors (LTNPs)...
  3. ncbi Hepatic safety profile of darunavir with low-dose ritonavir (DRV/r) in HIV/HCV coinfected and HIV monoinfected patients
    Giulia Morsica
    Department of Infectious Diseases, San Raffaele, Scientific Institute, Milan, Italy
    New Microbiol 34:317-21. 2011
    ..6xULN. This study showed evidence of long-lasting hepatic safety of ART including PI DRV/r in HIV/HCV coinfected and in HIV monoinfected persons...
  4. doi Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features
    G Morsica
    Dept of Infectious Diseases, S Raffaele Scientific Institute, Milan, Italy
    Infection 37:445-9. 2009
    ..An evaluation of the prevalence of occult hepatitis B virus (HBV) infection in HIV-positive individuals is important as HBV infection may have an impact on the outcome of the liver disease in these patients...
  5. doi Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients
    Giulia Morsica
    Department of Infectious Diseases, San Raffaele, Scientific Institute, Milan, Italy
    J Acquir Immune Defic Syndr 51:574-81. 2009
    ..To investigate the reciprocal inhibitory effects of hepatitis B virus (HBV)/hepatitis C virus (HCV)/hepatitis D virus (HDV) infections in naive and previously antiretroviral-experienced HIV-positive patients...
  6. ncbi Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy
    Giovanni Sitia
    Infectious Disease Department, San Raffaele Scientific Institute, Milan, Italy
    Antivir Ther 11:385-9. 2006
    ..Together, these results suggest that HIV infection may exacerbate the immune-mediated inflammatory response in the liver of patients chronically infected with HCV and antiretroviral therapy may prevent this effect...
  7. ncbi Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients
    Sabrina Bagaglio
    Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
    AIDS 19:S151-65. 2005
    ..Chronic hepatitis C virus (HCV) infection has occasionally been associated with diseases of the central nervous system, thus suggesting that the virus has a direct effect on cerebral function...
  8. doi Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs
    Hamid Hasson
    Department of Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
    Liver Int 33:1113-20. 2013
    ....
  9. ncbi HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study)
    Hamid Hasson
    Department of Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
    New Microbiol 35:469-74. 2012
    ..999) or the number of grade 3-4 AEs (p=0.146). No HIV failure was observed. The safety profile of LPV/r monotherapy was similar to that of LPV/r-based HAART, thus encouraging HAART simplification in patients receiving anti-HCV treatment...
  10. ncbi Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy
    Caterina Uberti-Foppa
    Department of Infectious Diseases, Vita Salute San Raffaele University, Via Stamira d Ancona 20, 20127 Milan, Italy
    J Acquir Immune Defic Syndr 33:146-52. 2003
    ..The authors also confirm that the baseline level of ALT is an important prognostic factor for increased liver damage during antiretroviral therapy...
  11. doi Surgical site infections in HIV-infected patients: results from an Italian prospective multicenter observational study
    C M J Drapeau
    2nd Infectious Diseases Division, National Institute for Infectious Diseases, L Spallanzani, Via Portuense 292, 00149, Rome, Italy
    Infection 37:455-60. 2009
    ..The aim of this study was to determine the incidence and the associated risk factors for SSI in HIV-infected patients...
  12. ncbi Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma
    Maria Stella De Mitri
    Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Bologna, Italy
    Liver Int 27:1126-33. 2007
    ....
  13. ncbi Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a
    Giulia Morsica
    AIDS 18:1080-2. 2004
  14. ncbi Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study
    Flavia Bortolotti
    Fifth Medical Clinic, University of Padova, Italy
    Hepatology 43:556-62. 2006
    ..Long-term monitoring is important, as is counseling on cofactors of liver damage, such as alcohol and drug abuse...
  15. ncbi The appropriate method of evaluating the dynamics of hepatitis B virus in patients receiving antiviral treatment: the other side of the coin
    Giulia Morsica
    AIDS 19:1933-4. 2005
  16. ncbi Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals
    Giorgio Antonucci
    National Institute of Infectious Diseases, L Spallanzani, Roma, Italy
    Antivir Ther 10:109-17. 2005
    ..These results suggest that GBV-C coinfection may play a role in determining the rate of HIV rebound possibly by competing with HIV replication after HIV load has been successfully suppressed by HAART...
  17. ncbi Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma
    Maria Stella De Mitri
    Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Bologna, Italy
    J Hepatol 36:116-22. 2002
    ..In 13 HCC cases sequence analysis was also performed in tumor and nontumor liver tissues...